Travere Therapeutics Eulerpool ニュース

Travere Therapeutics Eulerpool-AFX

Travere Therapeutics 株式ニュース

Travere Therapeuticsは世界中の多くのジャーナリストや投資家に注目されています。最新のTravere Therapeuticsニュースをここにまとめています。

• ·

  Yahoo
  Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference
• ·

  Thefly.com
  Travere Therapeutics price target raised by $5 at Canaccord, here's why
• ·

  Thefly.com
  Travere Therapeutics price target raised by $1 at BofA, here's why
• ·

  Seeking Alpha
  Travere gains on full FDA approval for kidney drug Filspari
• ·

  Yahoo
  Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• ·

  GlobeNewswire
  Travere Therapeutics Announces Full FDA Approval of FILSPARI? (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
• ·

  Thefly.com
  Travere Therapeutics' Filspari in kidney function granted full approval by FDA
• ·

  Yahoo
  High Growth Tech Stocks To Watch In September 2024
• ·

  TipRanks
  Buy Rating Affirmed for Travere Therapeutics Amid Positive KDIGO Guideline Developments and Filspari’s Market Potential
• ·

  TipRanks
  Travere Therapeutics (TVTX) Gets a Buy from Evercore ISI